Europe Recombinant Human Endostatin Market Research Report Forecast 2017-2021

1 Recombinant Human Endostatin Market Overview

1.1 Product Overview and Scope of Recombinant Human Endostatin

1.2 Classification of Recombinant Human Endostatin

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Application of Recombinant Human Endostatin

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Recombinant Human Endostatin Market States Status and Prospect (2012-2021) by Countries

1.4.1 Germany

1.4.2 France

1.4.3 UK

1.4.4 Russia

1.4.5 Italy

1.4.6 Spain

1.4.7 Benelux

1.5 Europe Market Size (Value and Volume) of Recombinant Human Endostatin (2012-2021)

1.5.1 Europe Recombinant Human Endostatin Sales and Growth Rate (2012-2021)

1.5.2 Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

2 Europe Economic Impact on Recombinant Human Endostatin Industry

2.1 Europe Macroeconomic Analysis

2.2 Europe Macroeconomic Environment Development Trend

3 Recombinant Human Endostatin Manufacturing Cost Analysis

3.1 Recombinant Human Endostatin Key Raw Materials Analysis

3.1.1 Key Raw Materials

3.1.2 Price Trend of Key Raw Materials

3.1.3 Key Suppliers of Raw Materials

3.1.4 Market Concentration Rate of Raw Materials

3.2 Proportion of Manufacturing Cost Structure

3.2.1 Raw Materials

3.2.2 Labor Cost

3.2.3 Manufacturing Process Analysis of Recombinant Human Endostatin

4 Industrial Chain, Sourcing Strategy and Downstream Buyers

4.1 Recombinant Human Endostatin Industrial Chain Analysis

4.2 Upstream Raw Materials Sourcing

4.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015

4.4 Downstream Buyers

5 Europe Recombinant Human Endostatin Market Analysis by Manufacturers, Type and Application

5.1 Europe Recombinant Human Endostatin Market Competition by Manufacturers

5.1.1 Europe Recombinant Human Endostatin Sales and Market Share of Key Manufacturers (2015 and 2016)

5.1.2 Europe Recombinant Human Endostatin Revenue and Share by Manufacturers (2015 and 2016)

5.2 Europe Recombinant Human Endostatin (Volume and Value) by Type

5.2.1 Europe Recombinant Human Endostatin Sales and Market Share by Type (2012-2017)

5.2.2 Europe Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)

5.3 Europe Recombinant Human Endostatin (Volume and Value) by Countries

5.3.1 Europe Recombinant Human Endostatin Sales and Market Share by Countries (2012-2017)

5.3.2 Europe Recombinant Human Endostatin Revenue and Market Share by Countries (2012-2017)

5.4 Europe Recombinant Human Endostatin (Volume) by Application

6 Germany Recombinant Human Endostatin (Volume, Value and Sales Price)

6.1 Germany Recombinant Human Endostatin Sales and Value (2012-2017)

6.1.1 Germany Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

6.1.2 Germany Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

6.1.3 Germany Recombinant Human Endostatin Sales Price Trend (2012-2017)

6.2 Germany Recombinant Human Endostatin Sales and Market Share by Manufacturers

6.3 Germany Recombinant Human Endostatin Sales and Market Share by Type

6.4 Germany Recombinant Human Endostatin Sales and Market Share by Application

7 France Recombinant Human Endostatin (Volume, Value and Sales Price)

7.1 France Recombinant Human Endostatin Sales and Value (2012-2017)

7.1.1 France Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

7.1.2 France Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

7.1.3 France Recombinant Human Endostatin Sales Price Trend (2012-2017)

7.2 France Recombinant Human Endostatin Sales and Market Share by Manufacturers

7.3 France Recombinant Human Endostatin Sales and Market Share by Type

7.4 France Recombinant Human Endostatin Sales and Market Share by Application

8 UK Recombinant Human Endostatin (Volume, Value and Sales Price)

8.1 UK Recombinant Human Endostatin Sales and Value (2012-2017)

8.1.1 UK Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

8.1.2 UK Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

8.1.3 UK Recombinant Human Endostatin Sales Price Trend (2012-2017)

8.2 UK Recombinant Human Endostatin Sales and Market Share by Manufacturers

8.3 UK Recombinant Human Endostatin Sales and Market Share by Type

8.4 UK Recombinant Human Endostatin Sales and Market Share by Application

9 Russia Recombinant Human Endostatin (Volume, Value and Sales Price)

9.1 Russia Recombinant Human Endostatin Sales and Value (2012-2017)

9.1.1 Russia Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

9.1.2 Russia Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

9.1.3 Russia Recombinant Human Endostatin Sales Price Trend (2012-2017)

9.2 Russia Recombinant Human Endostatin Sales and Market Share by Manufacturers

9.3 Russia Recombinant Human Endostatin Sales and Market Share by Type

9.4 Russia Recombinant Human Endostatin Sales and Market Share by Application

10 Italy Recombinant Human Endostatin (Volume, Value and Sales Price)

10.1 Italy Recombinant Human Endostatin Sales and Value (2012-2017)

10.1.1 Italy Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

10.1.2 Italy Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

10.1.3 Italy Recombinant Human Endostatin Sales Price Trend (2012-2017)

10.2 Italy Recombinant Human Endostatin Sales and Market Share by Manufacturers

10.3 Italy Recombinant Human Endostatin Sales and Market Share by Type

10.4 Italy Recombinant Human Endostatin Sales and Market Share by Application

11 Spain Recombinant Human Endostatin (Volume, Value and Sales Price)

11.1 Spain Recombinant Human Endostatin Sales and Value (2012-2017)

11.1.1 Spain Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

11.1.2 Spain Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

11.1.3 Spain Recombinant Human Endostatin Sales Price Trend (2012-2017)

11.2 Spain Recombinant Human Endostatin Sales and Market Share by Manufacturers

11.3 Spain Recombinant Human Endostatin Sales and Market Share by Type

11.4 Spain Recombinant Human Endostatin Sales and Market Share by Application

12 Benelux Recombinant Human Endostatin (Volume, Value and Sales Price)

12.1 Benelux Recombinant Human Endostatin Sales and Value (2012-2017)

12.1.1 Benelux Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

12.1.2 Benelux Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

12.1.3 Benelux Recombinant Human Endostatin Sales Price Trend (2012-2017)

12.2 Benelux Recombinant Human Endostatin Sales and Market Share by Manufacturers

12.3 Benelux Recombinant Human Endostatin Sales and Market Share by Type

12.4 Benelux Recombinant Human Endostatin Sales and Market Share by Application

13 Europe Recombinant Human Endostatin Manufacturers Analysis

13.1 Pfizer

13.1.1 Company Basic Information, Manufacturing Base and Competitors

13.1.2 Product Type, Application and Specification

13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.1.4 Business Overview

13.2 Biocon

13.2.1 Company Basic Information, Manufacturing Base and Competitors

13.2.2 Product Type, Application and Specification

13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.2.4 Business Overview

13.3 Mabtech

13.3.1 Company Basic Information, Manufacturing Base and Competitors

13.3.2 Product Type, Application and Specification

13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.3.4 Business Overview

13.4 Novartis

13.4.1 Company Basic Information, Manufacturing Base and Competitors

13.4.2 Product Type, Application and Specification

13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.4.4 Business Overview

13.5 Fujifilm Kyowa Kirin Biologics

13.5.1 Company Basic Information, Manufacturing Base and Competitors

13.5.2 Product Type, Application and Specification

13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.5.4 Business Overview

13.6 Enzon Pharmaceuticals

13.6.1 Company Basic Information, Manufacturing Base and Competitors

13.6.2 Product Type, Application and Specification

13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.6.4 Business Overview

13.7 Genexine

13.7.1 Company Basic Information, Manufacturing Base and Competitors

13.7.2 Product Type, Application and Specification

13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.7.4 Business Overview

13.8 Hetero Drugs

13.8.1 Company Basic Information, Manufacturing Base and Competitors

13.8.2 Product Type, Application and Specification

13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.8.4 Business Overview

13.9 Onyx Pharmaceuticals

13.9.1 Company Basic Information, Manufacturing Base and Competitors

13.9.2 Product Type, Application and Specification

13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.9.4 Business Overview

…

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Europe Recombinant Human Endostatin Market Forecast (2017-2021)

15.1 Germany Market Forecast (2017-2021)

15.2 France Market Forecast (2017-2021)

15.3 UK Market Forecast (2017-2021)

15.4 Russia Market Forecast (2017-2021)

15.5 Italy Market Forecast (2017-2021)

15.6 Spain Market Forecast (2017-2021)

15.7 Benelux Market Forecast (2017-2021)

15.8 Europe Recombinant Human Endostatin Market Forecast by Type (2017-2021)

15.9 Europe Recombinant Human Endostatin Market Forecast by Application (2017-2021)

16 Appendix

Table Classification of Recombinant Human Endostatin

Figure Europe Sales Market Share of Recombinant Human Endostatin by Type in 2015

Table Application of Recombinant Human Endostatin

Figure Europe Sales Market Share of Recombinant Human Endostatin by Application in 2015

Figure Germany Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure France Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure UK Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure Russia Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure Italy Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure Spain Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure Benelux Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Figure Europe Recombinant Human Endostatin Sales and Growth Rate (2012-2021)

Figure Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2021)

Table Europe Recombinant Human Endostatin Sales of Key Manufacturers (2015 and 2016)

Table Europe Recombinant Human Endostatin Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Recombinant Human Endostatin Sales Share by Manufacturers

Figure 2016 Recombinant Human Endostatin Sales Share by Manufacturers

Table Europe Recombinant Human Endostatin Revenue by Manufacturers (2015 and 2016)

Table Europe Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Recombinant Human Endostatin Revenue Share by Manufacturers

Table 2016 Europe Recombinant Human Endostatin Revenue Share by Manufacturers

Table Europe Recombinant Human Endostatin Sales and Market Share by Type (2012-2017)

Table Europe Recombinant Human Endostatin Sales Share by Type (2012-2017)

Figure Sales Market Share of Recombinant Human Endostatin by Type (2012-2017)

Figure Europe Recombinant Human Endostatin Sales Growth Rate by Type (2012-2017)

Table Europe Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)

Table Europe Recombinant Human Endostatin Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Recombinant Human Endostatin by Type (2012-2017)

Figure Europe Recombinant Human Endostatin Revenue Growth Rate by Type (2012-2017)

Table Europe Recombinant Human Endostatin Sales and Market Share by Countries (2012-2017)

Table Europe Recombinant Human Endostatin Sales Share by Countries (2012-2017)

Figure Sales Market Share of Recombinant Human Endostatin by Countries (2012-2017)

Table Europe Recombinant Human Endostatin Revenue and Market Share by Countries (2012-2017)

Table Europe Recombinant Human Endostatin Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Recombinant Human Endostatin by Countries (2012-2017)

Table Europe Recombinant Human Endostatin Sales and Market Share by Application (2012-2017)

Table Europe Recombinant Human Endostatin Sales Share by Application (2012-2017)

Figure Sales Market Share of Recombinant Human Endostatin by Application (2012-2017)

Figure Germany Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure Germany Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure Germany Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table Germany Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table Germany Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table Germany Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table Germany Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table Germany Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table Germany Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Figure France Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure France Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure France Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table France Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table France Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table France Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table France Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table France Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table France Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Figure UK Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure UK Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure UK Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table UK Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table UK Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table UK Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table UK Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table UK Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table UK Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Figure Russia Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure Russia Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure Russia Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table Russia Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table Russia Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table Russia Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table Russia Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table Russia Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table Russia Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Figure Italy Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure Italy Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure Italy Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table Italy Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table Italy Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table Italy Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table Italy Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table Italy Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table Italy Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Figure Spain Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure Spain Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure Spain Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table Spain Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table Spain Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table Spain Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table Spain Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table Spain Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table Spain Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Figure Benelux Recombinant Human Endostatin Sales and Growth Rate (2012-2017)

Figure Benelux Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)

Figure Benelux Recombinant Human Endostatin Sales Price Trend (2012-2017)

Table Benelux Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)

Table Benelux Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)

Table Benelux Recombinant Human Endostatin Sales by Type (2015 and 2016)

Table Benelux Recombinant Human Endostatin Market Share by Type (2015 and 2016)

Table Benelux Recombinant Human Endostatin Sales by Application (2015 and 2016)

Table Benelux Recombinant Human Endostatin Market Share by Application (2015 and 2016)

Table Pfizer Basic Information List

Table Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Biocon Basic Information List

Table Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biocon Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Mabtech Basic Information List

Table Mabtech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Mabtech Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Genexine Basic Information List

Table Genexine Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Genexine Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Table Hetero Drugs Recombinant Human Endostatin Sales Market Share (2012-2017)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Onyx Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2012-2017).

…

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Human Endostatin

Figure Manufacturing Process Analysis of Recombinant Human Endostatin

Figure Recombinant Human Endostatin Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015

Table Major Buyers of Recombinant Human Endostatin

Table Distributors/Traders List

Figure Germany Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure Germany Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Figure France Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure France Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Figure UK Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure UK Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Figure Russia Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure Russia Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Figure Italy Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure Italy Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Figure Spain Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure Spain Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Figure Benelux Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2021)

Figure Benelux Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)

Table Europe Recombinant Human Endostatin Sales Forecast by Type (2017-2021)

Table Europe Recombinant Human Endostatin Sales Forecast by Application (2017-2021)